Table of Contents
The internal neuromodulation market in Saudi Arabia, South Africa, and Turkey is a fast emerging market. The growth of this market is driven by factors such as public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and the increasingly aging population. However, factors such as the disadvantages of a dearth of skilled professional and the reimbursement scenario restrain the growth of this market.
The report has been broadly classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric neurostimulation. The spinal cord stimulator segment is further categorized on the basis of application into chronic pain, failed back surgery syndrome, ischemic pain, and others. Likewise, the deep brain stimulation market has its application in Parkinson’s disease, tremors, depression, and others that include chronic pain, dystonia, Tourette’s syndrome, and Alzheimer’s disease.
The sacral nerve stimulation market has applications in urinary incontinence and fecal incontinence. Vagus nerve stimulator comprises epilepsy and other applications; gastric stimulation includes gastroparaeisis and others. The gastric neurostimulator market segment is estimated to grow at the highest CAGR from 2014 to 2019. The drivers for this market are the increase in the number of people who suffer from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which is a major opportunity for players in this segment.
The market is estimated to be dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Aleva Neurotherapeutics SA (U.S.) Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the internal neuromodulation market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various applications of particular modalities of the internal neuromodulation market. The in-depth industry analysis of drivers, inhibitors, and industry trends has been captured in the report. The report also presents the therapy/modality market share analysis of top players country-wise and the company profiles of major companies of the market. It comprises and discusses the rudimentary views on the competitive landscape, emerging- and high-growth segments of the internal neuromodulation market, high-growth regions & countries & their respective regulatory policies.
The report will enrich both the established firms as well as new entrants/smaller firms. It gauges the pulse of the market, which in turn will help the firms garner the larger market share and better market presence. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share/presence.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on internal neurostimulation/neuromodulation modalities offered by the top 10 players in the market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the internal neuromodulation market
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Myasthenia Gravis in 26 Major Markets Myasthenia Gravis (MG), also known as autoimmune myasthenia, is one of the most significant diseases ...
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bell’s palsy in 15 Major Markets Bell's palsy, also known as idiopathic facial nerve palsy, is a weakness of the muscles on one side ...